Multitarget Pharmaceuticals LLC is categorized under Commercial Biotechnical Research in Salt Lake City, UT and active since 2004.
Multitarget Pharmaceuticals LLC was established in 2004, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Zhidong Chen at the company’s single location by writing to 825 North 300 West, Salt Lake City, Utah UT 84103 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Multitarget Pharmaceuticals LLC |
Contact Person: | Zhidong Chen |
Address: | 825 North 300 West, Salt Lake City, Utah 84103 |
Website Address: | aquaplasmid.com |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Multitarget Pharmaceuticals LLC was started in 2004 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Zhidong Chen for inquiries that concern Multitarget Pharmaceuticals LLC by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Multitarget Pharmaceuticals LLC can be found at the coordinates 40.787291,-111.899877 as well as the street address 825 North 300 West in Salt Lake City, Utah 84103.
For its online presence, you may visit Multitarget Pharmaceuticals LLC’s website at aquaplasmid.com and engage with its social media outlets through on Twitter and on Facebook.